Papillary and follicular thyroid cancer, together referred to as differentiated thyroid cancer
(DTC), is usually curable when discovered at an early stage. Its management, however, is …

Papillary and follicular (differentiated) thyroid carcinomas are among the most curable
cancers. However, some patients are at high risk for recurrent disease or even death. Most …

Thyroid carcinoma is rare among human malignancies (! 1%) but is the most frequent
endocrine cancer, accounting for about 5% of thyroid nodules (1). The latter are very …

Abstract purpose: To determine the long-term impact of medical and surgical treatment of
well differentiated papillary and follicular thyroid cancer. methods: Patients with papillary …

Differentiated thyroid carcinoma originates from thyroid follicular cells and is the most
prominent malignancy of the endocrine organs. There are two histological types of …

The incidence of differentiated thyroid cancer (DTC) has increased in many places around
the world over the past three decades, yet this has been associated with a significant …

GENERAL aspects of the diagnosis and management of differentiated thyroid carcinoma
(DTC) have been reviewed recently (1) and guidelines for management proposed (2). Yet …

Long-term survival rate for papillary and follicular carcinoma is more than 90%, but this
varies considerably among subsets of patients. About 30% of patients, however, develop …

DIFFERENTIATED thyroid carcinoma (papillary and follicular) is usually an indolent cancer,
but it may be aggressive, especially in patients more than 50 yr old. In those with more …

Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …